scholarly article | Q13442814 |
P2093 | author name string | Robert M Carey | |
P2860 | cites work | Renal Dopamine System | Q22241910 |
Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients | Q24324656 | ||
Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries | Q24338401 | ||
Disruption of the Ang II type 1 receptor promotes longevity in mice | Q24647615 | ||
International union of pharmacology. XXIII. The angiotensin II receptors | Q28138041 | ||
Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide | Q28205318 | ||
Intrarenal angiotensin III is the predominant agonist for proximal tubule angiotensin type 2 receptors | Q28569701 | ||
Distribution of angiotensin AT1 and AT2 receptor subtypes in the rat kidney | Q28571109 | ||
Renal angiotensin type 2 receptors mediate natriuresis via angiotensin III in the angiotensin II type 1 receptor-blocked rat | Q28580248 | ||
Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model | Q30304002 | ||
Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor | Q30304009 | ||
Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats | Q30305670 | ||
Angiotensin type 2 receptor-mediated hypotension in angiotensin type-1 receptor-blocked rats | Q30308406 | ||
Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation | Q30310896 | ||
Angiotensin AT2 receptors directly stimulate renal nitric oxide in bradykinin B2-receptor-null mice | Q30311190 | ||
Colocalization and release of angiotensin and renin in renal cortical cells | Q30311510 | ||
Subcellular characteristics of functional intracellular renin-angiotensin systems. | Q30417227 | ||
Mechanisms of dopamine D(1) and angiotensin type 2 receptor interaction in natriuresis | Q30422595 | ||
Identification and characterization of a functional mitochondrial angiotensin system | Q30427934 | ||
AT2 receptors: functional relevance in cardiovascular disease. | Q37274124 | ||
Effect of intrarenal angiotensin II blockade on renal function in conscious dogs | Q40057167 | ||
Role of the intrarenal renin-angiotensin system in the control of renal function | Q40123343 | ||
Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation | Q40851849 | ||
AT(2) receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions | Q42014112 | ||
Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors. | Q42740981 | ||
Vascular expression of angiotensin type 2 receptor in the adult rat: influence of angiotensin II infusion | Q43637801 | ||
AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade | Q44167938 | ||
Up-Regulation of Angiotensin II Type 2 Receptor in Rat Thoracic Aorta by Pressure-Overload | Q44650642 | ||
Stimulation of cyclic GMP production via AT2 and B2 receptors in the pressure-overloaded aorta after banding | Q44881068 | ||
Flow-dependent dilation mediated by endogenous kinins requires angiotensin AT2 receptors | Q44886524 | ||
Angiotensin II dilates bovine adrenal cortical arterioles: role of endothelial nitric oxide | Q46487926 | ||
Detection of dopamine receptor D1A subtype-specific mRNA in rat kidney by in situ amplification. | Q48540893 | ||
Angiotensin III stimulates aldosterone secretion from adrenal gland partially via angiotensin II type 2 receptor but not angiotensin II type 1 receptor. | Q54388735 | ||
Selective dopamine-1 receptor stimulation produces natriuresis by a direct tubular action | Q69903105 | ||
Selective renal dopamine-1 receptor stimulation in man | Q69904128 | ||
Decreased Plasma and Urinary Dopamine during Dietary Sodium Depletion in Man* | Q70764966 | ||
Control of renal function by intrarenal angiotensin II | Q71726250 | ||
Novel mechanism of hypertension revealed by cell-specific targeting of human angiotensinogen in transgenic mice | Q73031136 | ||
Angiotensin II/AT2 receptor-induced vasodilation in stroke-prone spontaneously hypertensive rats involves nitric oxide and cGMP-dependent protein kinase | Q79326913 | ||
Effects of angiotensin II and its metabolites in the rat coronary vascular bed: is angiotensin III the preferred ligand of the angiotensin AT2 receptor? | Q81356302 | ||
ANG II type 2 receptor regulates smooth muscle growth and force generation in late fetal mouse development | Q30434317 | ||
Cardiovascular and renal regulation by the angiotensin type 2 receptor: the AT2 receptor comes of age. | Q30436078 | ||
Intrarenal dopamine D1-like receptor stimulation induces natriuresis via an angiotensin type-2 receptor mechanism | Q30442186 | ||
Intrarenal aminopeptidase N inhibition augments natriuretic responses to angiotensin III in angiotensin type 1 receptor-blocked rats | Q30442448 | ||
Conversion of renal angiotensin II to angiotensin III is critical for AT2 receptor-mediated natriuresis in rats | Q30445290 | ||
The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats | Q30448817 | ||
The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats | Q30448844 | ||
Selective peripheral dopamine-1 receptor stimulation. Differential responses to sodium loading and depletion in humans | Q30448972 | ||
Selective peripheral dopamine-1 receptor stimulation with fenoldopam in human essential hypertension | Q30449406 | ||
Combined intrarenal blockade of the renin-angiotensin system in the conscious dog. | Q30454007 | ||
Dopamine-induced recruitment of dopamine D1 receptors to the plasma membrane | Q30454416 | ||
Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule | Q30459254 | ||
Diuresis and natriuresis during continuous dopamine-1 receptor stimulation | Q30461161 | ||
The effect of selective dopamine-1 receptor stimulation on renal and adrenal function in man. | Q30461163 | ||
Intrarenal dopamine acts at the dopamine-1 receptor to control renal function | Q30461616 | ||
Localization of dopamine D1A receptor protein in rat kidneys | Q30464303 | ||
Renal interstitial fluid angiotensin. Modulation by anesthesia, epinephrine, sodium depletion, and renin inhibition | Q30464938 | ||
Expression of the subtype 1A dopamine receptor in the rat heart | Q30468198 | ||
Renin-angiotensin system modulates renal bradykinin production | Q30469571 | ||
Intrarenal dopamine production and distribution in the rat. Physiological control of sodium excretion | Q30470064 | ||
Bradykinin B2 receptor modulates renal prostaglandin E2 and nitric oxide | Q30470112 | ||
Localization of the dopamine D1 receptor protein in the human heart and kidney | Q30471091 | ||
Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney | Q30471269 | ||
Immunolocalization of subtype 2 angiotensin II (AT2) receptor protein in rat heart | Q30472368 | ||
Selective inhibition of the renal dopamine subtype D1A receptor induces antinatriuresis in conscious rats | Q30473116 | ||
Stimulation of angiotensin AT2 receptors by the non-peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats. | Q33685969 | ||
Angiotensin II stimulates thick ascending limb NO production via AT(2) receptors and Akt1-dependent nitric-oxide synthase 3 (NOS3) activation | Q33832746 | ||
Intratubular renin-angiotensin system in hypertension | Q34777649 | ||
Angiotensin AT2 receptors: cardiovascular hope or hype? | Q35045801 | ||
Functional role of angiotensin II AT2 receptor in modulation of AT1 receptor‐mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxide | Q35045808 | ||
Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice | Q35572452 | ||
Novel roles of nuclear angiotensin receptors and signaling mechanisms | Q35850244 | ||
Angiotensin II type 2 receptor-mediated inhibition of NaCl absorption is blunted in thick ascending limbs from Dahl salt-sensitive rats | Q36190829 | ||
Angiotensin II AT(2) receptor decreases AT(1) receptor expression and function via nitric oxide/cGMP/Sp1 in renal proximal tubule cells from Wistar-Kyoto rats | Q36994675 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dopamine | Q170304 |
P304 | page(s) | 673-680 | |
P577 | publication date | 2013-03-01 | |
P1433 | published in | Hypertension | Q5958695 |
P1476 | title | The intrarenal renin-angiotensin and dopaminergic systems: control of renal sodium excretion and blood pressure | |
P478 | volume | 61 |
Q64057119 | A new common functional coding variant at the DDC gene change renal enzyme activity and modify renal dopamine function |
Q30275852 | AT2 Receptors: Potential Therapeutic Targets for Hypertension |
Q35236405 | Angiotensin type 2 receptors: blood pressure regulation and end organ damage |
Q91939871 | Angiotensin-converting enzyme insertion/deletion gene polymorphisms and the risk of glioma in an Algerian population |
Q38947590 | Antenatal betamethasone attenuates the angiotensin-(1-7)-Mas receptor-nitric oxide axis in isolated proximal tubule cells. |
Q35671840 | Antenatal glucocorticoid treatment alters Na+ uptake in renal proximal tubule cells from adult offspring in a sex-specific manner |
Q33821039 | Atrial natriuretic peptide and renal dopaminergic system: a positive friendly relationship? |
Q64108760 | Diabetes and Hypertension Differentially Affect Renal Catecholamines and Renal Reactive Oxygen Species |
Q38389015 | Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure). |
Q30235047 | Do renin-angiotensin system inhibitors influence the recurrence, metastasis, and survival in cancer patients?: Evidence from a meta-analysis including 55 studies |
Q36363450 | Enhanced Natriuresis and Diuresis in Wistar Rats Caused by the Costimulation of Renal Dopamine D3 and Angiotensin II Type 2 Receptors |
Q50457521 | G-Protein-Coupled Receptor Signaling in Cilia. |
Q42080888 | ISN Forefronts Symposium 2015: Maintaining Balance Under Pressure-Hypertension and the Proximal Tubule |
Q36837774 | Kidney tubules: intertubular, vascular, and glomerular cross-talk |
Q37235107 | Local Renin-Angiotensin system in the reproductive system |
Q37092421 | Maintaining Balance Under Pressure: Integrated Regulation of Renal Transporters During Hypertension |
Q28255579 | Peripheral and central effects of circulating catecholamines |
Q43143871 | Reciprocal effect of angiotensin II in collecting duct renin synthesis |
Q22241156 | Renal dopaminergic system: Pathophysiological implications and clinical perspectives |
Q52903938 | Resetting of renal tissular renin-angiotensin and bradykinin-kallikrein systems after unilateral kidney denervation in rats. |
Q37604306 | Roles of dopamine receptor on chemosensory and mechanosensory primary cilia in renal epithelial cells. |
Q38287148 | Salt feedback on the renin-angiotensin-aldosterone system |
Q38272996 | Signaling pathways involved in renal oxidative injury: role of the vasoactive peptides and the renal dopaminergic system |
Q64901457 | The Relationship between the Intrarenal Dopamine System and Intrarenal Renin-angiotensin System Depending on the Renal Function. |
Q30360038 | The renal dopaminergic system: novel diagnostic and therapeutic approaches in hypertension and kidney disease. |
Search more.